AbbVie Inc said on Tuesday it signed a U.S. licensing deal with Mylan NV for its proposed biosimilar to AbbVie's blockbuster drug Humira, in a move that will give it more near-term control over the competition.
Swiss drugmaker Roche's hopes of recapturing lost ground in the generics-flooded influenza market got a boost after a late-stage study showed its new medicine reduced symptoms in people at high risk of complications.
A federal judge ruled on Monday against birth control organizations that sought to block the Trump administration from shifting a federal family-planning grant program toward prioritizing groups that are faith-based and counsel abstinence.
Swiss drugmaker Roche's hopes of regaining ground in the influenza market have been boosted after a late-stage study showed its investigational drug baloxavir marboxil reduced symptoms in people at high risk of complications.
A mass radio campaign in Burkina Faso led to a significant rise in sick children getting medical attention and could prove one of the most cost-effective ways to save young lives in poor countries, researchers said on Tuesday.
The use of gene editing technologies to alter the DNA of human embryos could be morally permissible as long as the science and its impact on society is carefully considered, a British ethics panel said on Tuesday.
A court hearing on a Texas law requiring the burial or cremation of aborted fetal tissue opened on Monday with the state arguing the requirement was a matter of dignity, while abortion providers called it unnecessary and aimed at impeding clinic operations.
(Reuters Health) - While most adults know nicotine is bad for children, smokers and some other individuals aren't convinced of this fact, according to a U.S. study that suggests a need for more public education about the risks of tobacco.
(Reuters Health) - Patients with common colds and respiratory illnesses may be more likely to get antibiotics - which don't work for these conditions - when they go to an urgent care clinic, a U.S. study suggests.
China's new medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on patients, state news agency Xinhua said on Saturday.
A U.S. court has granted Indivior a preliminary injunction blocking India's Dr. Reddy's Laboratories from selling cut-price versions of the British drugmaker's best-selling opioid addiction treatment in the United States, Indivior said on Friday.
NEW YORK (Reuters Health) - There is a new epidemic of hepatitis C, HIV, and other infections within the opioid abuse epidemic, according to participants in a National Academies of Sciences, Engineering, and Medicine workshop.
Johnson & Johnson has vowed to appeal a $4.7 billion verdict awarded to 22 women who claim asbestos-contaminated talc in the company's products gave them ovarian cancer by arguing the plaintiffs' science was flawed and the case should not have been heard in Missouri.
(Reuters Health) - Changing the criminal penalties for drug possession could reduce racial and ethnic disparities in the criminal justice system and indirectly reduce health disparities as well, researchers say.
A U.S. appeals court on Friday ruled invalid patents owned by Jazz Pharmaceuticals PLC covering its narcolepsy drug Xyrem, giving Amneal Pharmaceuticals Inc a boost in its effort to launch a generic version of the medicine.